These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15564102)

  • 21. Red blood cells, plasma, and other new apheresis-derived blood products: improving product quality and donor utilization.
    Smith JW; Gilcher RO
    Transfus Med Rev; 1999 Apr; 13(2):118-23. PubMed ID: 10218235
    [No Abstract]   [Full Text] [Related]  

  • 22. The harmonization of the regulation of blood products: a European perspective.
    Seitz R; Heiden M; Nübling CM; Unger G; Löwer J
    Vox Sang; 2008 May; 94(4):267-76. PubMed ID: 18179678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Computerization of hospital blood banks in France].
    Daurat G; Py JY
    Transfus Clin Biol; 2012 Nov; 19(4-5):218-23. PubMed ID: 23039955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality requirements and quality assurance of leukocyte-depleted blood components.
    Myllylä G
    Curr Stud Hematol Blood Transfus; 1994; (60):111-22. PubMed ID: 8088164
    [No Abstract]   [Full Text] [Related]  

  • 25. [Inspection of transfusion sites by the French Blood Establishment].
    Chevrolle F; Hadzlik E; Suchel PL
    Transfus Clin Biol; 2001 Dec; 8(6):485-9. PubMed ID: 11802612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic applications and promises of cellular and tissue engineering. What strategic choice for the Etablissement Français du Sang?].
    Hervé P
    Transfus Clin Biol; 2007 May; 14(1):3-9. PubMed ID: 17485235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Safety of plasma products may be improved].
    Wahlberg T
    Lakartidningen; 1995 Dec; 92(51-52):4869-70. PubMed ID: 8544500
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple apheresis].
    Coffe C
    Transfus Clin Biol; 2007 May; 14(1):86-9. PubMed ID: 17521944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evolution of the practices of labile blood product distribution].
    Tardivel R
    Transfus Clin Biol; 2005 Jun; 12(2):177-9. PubMed ID: 15894509
    [No Abstract]   [Full Text] [Related]  

  • 31. The potential usefulness of thrombelastography in quality monitoring and quality improvement of blood components.
    Seghatchian J
    Transfus Apher Sci; 2009 Dec; 41(3):227-8. PubMed ID: 19800846
    [No Abstract]   [Full Text] [Related]  

  • 32. [For a reform of the legislation applied to plasma derivatives].
    Pellet R
    Rev Neurol (Paris); 2009 May; 165 Suppl 3():S88-94. PubMed ID: 19524100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of continuous education in transfusion for professionals in hospitals and clinics].
    Courbil R; Fabrigli P; Odent-Malaure H; Carrières J; Chartier M; Fressy P; Quaranta JF; Garraud O
    Transfus Clin Biol; 2007 Oct; 14(4):420-32. PubMed ID: 17921001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Do we have a good blood supply?].
    Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Oct; 56(10):1349-51. PubMed ID: 24162028
    [No Abstract]   [Full Text] [Related]  

  • 35. [Towards bacterial detection in labile blood products].
    Morel P
    Transfus Clin Biol; 2005 Jun; 12(2):215-20. PubMed ID: 15894499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical microbiology laboratories in Dutch hospitals: essential for safe patient care].
    Bonten MJ
    Ned Tijdschr Geneeskd; 2008 Dec; 152(49):2650-2. PubMed ID: 19137961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy].
    Heim MU
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):186-97; quiz 199. PubMed ID: 19266420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Possible actions to guide international cooperation programs].
    Beauplet A
    Transfus Clin Biol; 2006 Sep; 13(3):206-10. PubMed ID: 16938477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative pay-for-performance scoring methods: implications for quality improvement and patient outcomes.
    Glickman SW; Boulding W; Roos JM; Staelin R; Peterson ED; Schulman KA
    Med Care; 2009 Oct; 47(10):1062-8. PubMed ID: 19648833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Partnership guide for the good sequence of a blood donation].
    Courbil R; Chenus F; Julien H; Ruyer-Dumontier P; Garraud O
    Transfus Clin Biol; 2008 Sep; 15(4):160-7. PubMed ID: 18789744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.